Critical roles of non-histone protein lysine methylation in human tumorigenesis
REVIEWS
contacts42. This result reveals that increased hydropho Furthermore, Shi et al.47 reported that the protein bicity of lysine residues by methylation can enhance lysine methyltransferase SETD8 monomethylates p53 the promoter binding ability of transcription factors.at lysine 382 and that this methylation suppresses
p53 dependent transcription activation in cancer
Non-histone PKMT and PKDM substratescells. Taken together, these results indicate that lysine So far, nearly 20 non histone substrates have been dis methylation is an important regulator of p53 function.covered for PKMTs and PKDMs (TABLE 1). Many PKMTs
and PKDMs are localized in the nucleus, and several RB1 and E2F. RB1 is a key cell cycle regulator and tumour nuclear proteins, including transcription factors, can suppressor, and is dysfunctional in several cancer types48. serve as substrates of PKMTs and PKDMs. However, RB1 was identified as a binding partner for mitogenic several PKMTs or PKDMs are also localized in the cyto oncoproteins49 and was also discovered to be phosphoryl plasm, and cytoplasmic proteins are also reported to ated in synchrony with the cell cycle50. Recently, we and be substrates of these enzymes. Below, we highlight the others reported that lysine methylation of RB1 seems to lysine methylation of non histone proteins involved in be one of the substantial regulators of RB1 function and is several tumour associated signalling pathways.pivotal for cell cycle regulation22,51,52. Methylation at lysine
810 of RB1 by SMYD2 is likely to enhance phosphory
p53. p53 is one of the most important tumour sup lation of RB1 at serines 807 and 811 (REF. 22). Additionally, pressor genes involved in human tumorigenesis43. although RB1 normally interacts with E2F (a family of Chuikov et al.39 demonstrated that SETD7 methyl transcription factors that modulate important cellular ates lysine 372 of p53 (p53K372) and that this meth events, including cell cycle progression, apoptosis and ylation enhances p53 stability and transcriptional DNA damage response53) to suppress transcription of activity. K372 methylated p53 is restricted to the E2F target genes, lysine 810 methylation of RB1 acceler nucleus, although p53 is equally distributed between ates E2F transcriptional activity through enhancement of the nuclear and cytosolic fractions39. Subsequently, RB1 phosphorylation and promotes cell cycle progression Huang et al.44 showed that the PKMT SET and (FIG. 3b). Furthermore, we identified that lysine 442 of pro MYND domain containing 2 (SMYD2) monometh tein phosphatase 1, regulatory subunit 12A (PPP1R12A; ylates lysine 370 of p53 (p53K370); this lysine residue also called MYPT1) in the myosin phosphatase holo is located in the regulatory domain at the extreme enzyme, which stimulates dephosphorylation of RB1, is carboxyl terminus of p53 (FIG. 3a). Knockdown a target for methylation and demethylation catalysed by of SMYD2 by small interfering RNA enhances SETD7 and LSD1, respectively24 (FIG. 3b). Demethylation p53 mediated apoptosis in cancer cells44. In addition, of PPP1R12A by LSD1 enhances PPP1R12A polyubiq SMYD2 dependent p53K370 methylation impairs uitylation, which increases the proteasome mediated the expression of CDKN1A, an important down degradation of PPP1R12A and therefore the amount of stream target of p53, implying that SMYD2 represses phosphorylated RB1. Subsequently, released E2F acti the function of p53 through K370 monomethylation. vates transcription genes required for S phase, and cell Moreover, p53K372 methylation by SETD7 seems cycle progression is enhanced24. Together, methylation to inhibit SMYD2 depedent p53K370 methylation and demethylation dynamics seems to play an impor through blocking the interaction between SMYD2 tant part in cell cycle progression through the regulation and p53 (REFS 39,44) (FIG. 3a).of RB1 activity.The function of monomethylation and dimethylation Deregulated expression or activity of members of p53 on lysine 370 seems to be different. For example, of the E2F family has also been detected in many LSD1 was reported to demethylate p53K370 and repress human cancers54. Kontaki et al.55 demonstrated that in p53 activity45 (FIG. 3a). In this case, LSD1 preferentially p53 deficient cancer cells, methylation of lysine 185 of reverses dimethylated p53K370 in cancer cells, although E2F1 (E2F1K185) by SETD7 inhibits acetylation and it can remove both monomethylation and dimethylation phosphorylation at distant positions and, in parallel, at lysine 370 in biochemical reactions in vitro45. p53K370 induces polyubiquitylation and degradation of E2F1. dimethylation promotes the association of p53 with the This process prevents E2F1 accumulation during co activator p53 binding protein 1 (p53BP1) through DNA damage and activation of its pro apoptotic tar tandem Tudor domains in p53BP1 (REF. 45), leading to get gene TP73 (FIG. 3b). Moreover, LSD1 demethylates increased p53 function, including apoptosis induc E2F1K185, which is important to maintain a substan tion. These results indicate that monomethylation of tial pool of unmethylated E2F1 in cancer cells, which p53K370 is crucial for the repression of p53 activity, can then be subjected to lysine acetyltransferase 2B whereas dimethylation of p53K370 seems to activate (KAT2B) mediated hyper acetylation, as well as check p53. The complexity of methylation pathways in human point kinase 2 (CHEK2) mediated phosphorylation, cancer is highlighted by the fact that both SMYD2 and following DNA damage55 (FIG. 3b). These results imply LSD1 affect the same lysine residue of p53, and that that in p53 deficient cancer cells, LSD1 and SETD7 both of these enzymes can promote oncogenesis and are can influence DNA damage induced cell death in a overexpressed in various types of cancer22,46. It is plau manner that is in contrast to the aforementioned sible that their oncogenic actions on p53 may be syn p53 dependent apoptosis induction regulated by ergistic, although they could also have effects on other LSD1 and SETD7. These results suggest that antican cancer related pathways.cer treatments that combine DNA damaging agents
Tudor domains
Protein domains originally
identified as a region of 50 amino acids found in the Drosophila melanogaster
Tudor protein. The structurally characterized Tudor domain in human proteins recognizes symmetrically dimethylated arginine. This domain is also reported as a methyl
lysine binding protein module.
CANCER
Lysine Methylation - Structure 2006_经管营销_专业...a critical step in X-ray structure determination.... notably in the interaction of histone tails with...
roles for specific loci in some cell types (...Methylation of histone H3 lysine 9 can be bound... heterochromatin protein 1; HMT, histone ...
ected in their critical roles in control of gene...Among the known histone modi?cations, lysine ... component MBD2 by protein arginine methylation. ...
The profile of repeat-associated histone lysine methylation states in the mouse epigenome_生物学_自然科学_专业资料。The profile of repeat-associated histone...
Crystal structure of human histone lysine-specific...catalytic mechanism and the functional roles of ... methylation, phosphorylation, and ubiquitination, ...
considered to be critical for epigenetic repression...a, Purified UTX protein demethylates H3K27me3 but...Role of histone H3 lysine 27 methylation in X ...
‘histone code’ together with lysine methylation ...The full extent of regulatory roles of protein ...Gordon Leitch for critical reading on the ...
(HKMTs) or histone lysine demethylases (HKDMs) may have critical roles in ...Natural history of the eukaryotic chromatin protein methylation system. Prog. ...
epigenetic changes also play a critical role in... and most commonly include increased methylation of...non-histone protein targets implicated in ...
epigenetic changes also play a critical role in... and most commonly include increased methylation of...non-histone protein targets implicated in ...
热门文档